Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma

BackgroundLutetium 177 (177Lu) - DOTATATE is a form of peptide receptor radionuclide therapy (PRRT) utilized in the treatment of neuroendocrine tumors. Data on 177Lu-DOTATATE-induced thyroid dysfunction is limited.Case DescriptionA 29-year-old male with SDHB positive metastatic paraganglioma enrolle...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Sriram Gubbi, Mohammad Al-Jundi, Jaydira Del Rivero, Abhishek Jha, Marianne Knue, Joy Zou, Baris Turkbey, Jorge Amilcar Carrasquillo, Emily Lin, Karel Pacak, Joanna Klubo-Gwiezdzinska, Frank I-Kai Lin
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2021-01-01
Serija:	Frontiers in Endocrinology
Teme:	DOTATATE Lutathera hypothyroidism peptide receptor radionuclide therapy paraganglioma
Online dostop:	https://www.frontiersin.org/articles/10.3389/fendo.2020.587065/full
Oznake:	Označite Brez oznak, prvi označite!